Cargando…

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

Tumor cells are characterized as redox-heterogeneous intracellular microenvironment due to the simultaneous overproduction of reactive oxygen species and glutathione. Rational design of redox-responsive drug delivery systems is a promising prospect for efficient cancer therapy. Herein, six paclitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Bingjun, Luo, Cong, Zhang, Xuanbo, Guo, Mengran, Sun, Mengchi, Yu, Han, Chen, Qin, Yang, Wenqian, Wang, Menglin, Zuo, Shiyi, Chen, Pengyu, Kan, Qiming, Zhang, Haotian, Wang, Yongjun, He, Zhonggui, Sun, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642185/ https://www.ncbi.nlm.nih.gov/pubmed/31324811 http://dx.doi.org/10.1038/s41467-019-11193-x

Ejemplares similares

Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy
por: Zhang, Shenwu, et al.
Publicado: (2021)

Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy
por: Zhang, Shenwu, et al.
Publicado: (2017)

Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy
por: Li, Yaqiao, et al.
Publicado: (2022)

Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies
por: Wang, Yuequan, et al.
Publicado: (2021)

Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies
por: Li, Lingxiao, et al.
Publicado: (2021)

Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment
por: Liu, Tian, et al.
Publicado: (2022)

Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies
por: Wang, Xin, et al.
Publicado: (2021)

Elaborately Engineering a Self‐Indicating Dual‐Drug Nanoassembly for Site‐Specific Photothermal‐Potentiated Thrombus Penetration and Thrombolysis
por: Zhao, Zhiqiang, et al.
Publicado: (2021)

Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity
por: Yang, Yinxian, et al.
Publicado: (2020)

Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors
por: Sun, Mengchi, et al.
Publicado: (2022)

Pure photosensitizer-driven nanoassembly with core-matched PEGylation for imaging-guided photodynamic therapy
por: Zhang, Shenwu, et al.
Publicado: (2021)

Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy
por: Shan, Xinzhu, et al.
Publicado: (2021)

Cytochrome P450 enzyme-mediated auto-enhanced photodynamic cancer therapy of co-nanoassembly between clopidogrel and photosensitizer
por: Wang, Qiu, et al.
Publicado: (2020)

Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers
por: Li, Meng, et al.
Publicado: (2019)

Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy
por: Zhang, Xuanbo, et al.
Publicado: (2021)

A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
por: Sun, Yixin, et al.
Publicado: (2019)

Efficient Intestinal Digestion and On Site Tumor‐Bioactivation are the Two Important Determinants for Chylomicron‐Mediated Lymph‐Targeting Triglyceride‐Mimetic Docetaxel Oral Prodrugs
por: Tian, Chutong, et al.
Publicado: (2019)

Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
por: Yang, Yinxian, et al.
Publicado: (2021)

Polydopamine-modified ROS-responsive prodrug nanoplatform with enhanced stability for precise treatment of breast cancer
por: Yang, Bin, et al.
Publicado: (2019)

Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel
por: Ding, Dawei, et al.
Publicado: (2019)

Photoresponsive prodrug‐dye nanoassembly for in‐situ monitorable cancer therapy
por: Long, Kaiqi, et al.
Publicado: (2022)

Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
por: Lou, Xinyu, et al.
Publicado: (2021)

Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy
por: Liu, Yuting, et al.
Publicado: (2023)

Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018)

Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction‐Sensitive Nanoparticles at the “Cellular Level” and Synergize PD‐1 Blockade Therapy
por: Dong, Songtao, et al.
Publicado: (2022)

Self-adaptive nanoassembly enabling turn-on hypoxia illumination and periphery/center closed-loop tumor eradication
por: Wang, Ziyue, et al.
Publicado: (2023)

Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy
por: Zhou, Yong, et al.
Publicado: (2023)

Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
por: Zuo, Shiyi, et al.
Publicado: (2021)

Dynamic nanoassemblies derived from small-molecule homodimeric prodrugs for in situ drug activation and safe osteosarcoma treatment
por: Wang, Jian, et al.
Publicado: (2023)

Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope
por: Lou, Xinyu, et al.
Publicado: (2021)

Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy
por: Du, Yuqian, et al.
Publicado: (2018)

Cancer-speciﬁc calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced anti-metastasis combinational chemotherapy
por: Li, Dan, et al.
Publicado: (2021)

Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy
por: Zhong, Lu, et al.
Publicado: (2019)

Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy
por: Zhong, Zhi-Xin, et al.
Publicado: (2023)

Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
por: Wu, Pengkai, et al.
Publicado: (2022)

Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era
por: Ling, Hao, et al.
Publicado: (2022)

Insights into the Structure and Energy of DNA Nanoassemblies §
por: Jaekel, Andreas, et al.
Publicado: (2020)

Layer-by-Layer Nanoassemblies for Vaccination Purposes
por: Guzmán, Eduardo, et al.
Publicado: (2023)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
por: Yu, Jiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5k2f6vp2pa5aipiemh0pjbeso9